Global /United States /Healthcare /Medical Instruments & Supplies /ALGN
chevron_leftBack

Align Technology, Inc.

ALGN
NASDAQ: ALGN Delayed
177.23USD 1.9%
As of 24 April 2025, Align Technology, Inc. has a market cap of $12.98B USD, ranking #1362 globally and #515 in the United States. It ranks #115 in the Healthcare sector, and #16 in the Medical Instruments & Supplies industry.
Global Rank
1362
Country Rank
515
Sector Rank
115
Industry Rank
16
Key Stats
Market Cap
$12.98BUSD
Enterprise Value
$12.05BUSD
Revenue (TTM)
$4.0BUSD
EBITDA (TTM)
$820.6MUSD
Net Income (TTM)
$421.36MUSD
EBITDA Margin
21%
Profit Margin
11%
PE Ratio
31.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Joseph Hogan open_in_new
Employees
20,945
Founded
1997
Website
aligntech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.9% 6.2% 5.3% -24% -16% -41%
Upcoming Earnings
Earnings Date
Wed, Apr 30
Earnings Time
bedtime After Close
EPS Estimate
$2.02 -5.6% yoy
Revenue Estimate
$977.9M -2% yoy

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ALGN
Align Technology Inc
ISIN: US0162551016
Shares Out.:
73.21M1 Shares Float: 68.575M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
177.23 USD
London Stock Exchange
MIC: XLON
0HCK
Align Technology Inc
ISIN: US0162551016
TV:
SA:
YF:
GF:
BA:
MS:
174.57 USD
Mexican Bolsa
MIC: XMEX
ALGN
Align Technology Inc
ISIN: US0162551016
TV:
SA:
YF:
GF:
BA:
MS:
3.3K MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Align Technology, Inc.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; as well as Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. The Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing (CAD/CAM) software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient’s historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Similar Companies

Industry: Medical Instruments & Supplies (United States)
Name
Market Cap diff.
Intuitive Surgical, Inc.
ISRG
$174.81B
1K%
Becton, Dickinson and Co.
BDX
$58.09B
348%
ResMed Inc.
RMD
$31.44B
142%
The Cooper Companies, Inc.
COO
$16.17B
25%
West Pharmaceutical Services, Inc.
WST
$15.77B
22%
Industry: Medical Instruments & Supplies (Global)
Name
Market Cap diff.
EssilorLuxottica Société anonyme
EL
$133.72B
117.51B EUR
931%
Alcon Inc.
ALC
$46.68B
38.55B CHF
260%
HOYA Corp.
7741
$38.56B
5.49T JPY
197%
Terumo Corp.
4543
$28.62B
4.08T JPY
121%
Coloplast A/S
COLO-B
$24.61B
161.44B DKK
90%